The Kleihauer-Betke test is a laboratory method that detects fetal red blood cells circulating in a pregnant person’s bloodstream, indicating that blood has crossed the placenta from fetus to mother. First described in the late 1950s, the test works on a simple chemical principle: fetal hemoglobin resists acid far better than adult hemoglobin. Despite well-documented accuracy limitations and the availability of newer technology, it remains one of the most widely used tools for managing Rh-negative pregnancies and evaluating suspected fetomaternal hemorrhage.
How the Acid Elution Principle Works
A thin smear of maternal blood is placed on a glass slide, fixed in alcohol, and then exposed to an acidic solution. The acid washes away (elutes) adult hemoglobin from the mother’s red blood cells, leaving them pale and essentially empty, sometimes called “ghost cells.” Fetal red blood cells, loaded with a form of hemoglobin that is structurally more resistant to acid, retain their contents and stain darkly with a counterstain. A technician then counts how many darkly stained fetal cells appear among a field of pale maternal cells and calculates a ratio, which can be converted into an estimate of how much fetal blood has entered the mother’s circulation.
The staining and elution steps are more finicky than that summary suggests. In the Shepard variation of the technique, slides are fixed for five minutes in 80% ethanol, then immersed in a solution of iron, hydrochloric acid, and hematoxylin for about twenty seconds. After washing, they go into an erythrosine solution that stains remaining alkaline structures, including intact fetal hemoglobin and cell membranes, a contrasting pink or red color.1PubMed Central. Development of a new staining protocol for the Kleihauer–Betke test to facilitate the reading of difficult cases Small variations in acid concentration, temperature, immersion time, and the amount of blood on the slide can all shift results, which is one reason the test has a reputation for inconsistency across labs.
Why Clinicians Order It
The test has two main jobs. The first, and most common, is determining how much anti-D immunoglobulin (commonly known by the brand name RhoGAM) an Rh-negative mother needs after an event that could cause fetal blood to enter her system. A standard dose of anti-D immunoglobulin covers roughly 30 mL of fetal blood. If the hemorrhage is larger than that, additional doses are needed. Canadian obstetric guidelines, for example, specifically recommend quantitative testing with the KB test or flow cytometry after 20 weeks of gestation in Rh D-negative individuals who have a suspected fetomaternal hemorrhage, so that the anti-D dose can be properly tailored.2Journal of Obstetrics and Gynaecology Canada. Guideline No. 445: Prevention of Rh D Alloimmunization
The second job is broader: investigating any situation where fetal blood might have leaked into the maternal circulation and the clinical team needs to know the volume. That includes placental abruption, unexplained stillbirth, neonatal anemia without an obvious cause, and maternal trauma. In the case of stillbirth and neonatal anemia, the test is often prescribed as part of an etiological workup to determine whether a large fetomaternal hemorrhage contributed to the outcome.3PubMed. Pregnancy bleeding during second and third trimester: Is the Kleihauer-Betke test really useful?
Reading the Results
The KB result is usually reported as a percentage of fetal cells among total red blood cells counted on the slide. From that percentage, a formula estimates the volume of fetal blood that has entered the mother’s circulation, typically by multiplying the percentage by an assumed maternal blood volume (around 5,000 mL for an average-sized woman at term). A result of 0.1% fetal cells, for instance, would suggest roughly 5 mL of fetal blood, which is within the range covered by a single standard dose of anti-D immunoglobulin. Higher percentages signal larger hemorrhages that need more aggressive intervention.
In practice, clinicians mostly care about two thresholds. The first is whether any fetal cells are present at all, which confirms that fetomaternal hemorrhage has occurred. The second is whether the estimated volume exceeds 30 mL of fetal whole blood, the approximate coverage of one standard vial of anti-D immunoglobulin. If it does, repeat doses are needed. A study examining Rh D-negative pregnant women in Addis Ababa found detectable fetomaternal hemorrhage by KB test in about half of participants, with the great majority of those cases involving less than 10 mL of fetal blood and only about one percent exceeding 30 mL.4BMC Pregnancy and Childbirth. Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia That pattern holds generally: most fetomaternal hemorrhages are small, and the KB test’s primary clinical value lies in catching the uncommon large ones.
The Accuracy Problem
The KB test’s biggest weakness is that it depends on a human being sitting at a microscope, counting cells and judging which ones are “dark enough” to be fetal. This introduces significant subjectivity. One study found that when a set of prepared slides was assessed at a different hospital, agreement was only 46%, and when technicians attempted to quantify the actual number of fetal cells, differences of over 500% were observed between readers.5BJOG: An International Journal of Obstetrics & Gynaecology. The Kleihauer Technique: an accurate method of quantifying fetomaternal haemorrhage? That is a staggering range for a test that guides medication dosing. The authors called for quality control measures and audits so laboratories could identify and fix deficiencies in their technique.
Part of the problem is that the boundary between a “ghost cell” and a “fetal cell” is not always crisp. Some maternal cells retain a faint blush of staining, and some fetal cells do not stain as darkly as expected. Different labs use slightly different acid concentrations, immersion times, and staining protocols, which further muddies comparisons. Researchers have attempted to improve reliability by standardizing the protocol more tightly. One recent approach experimented with acetic acid at a pH of about 3.09, bovine serum albumin as a membrane stabilizer, and methylene blue combined with erythrosine to sharpen the color contrast between fetal and maternal cells.6PubMed Central. Development of a new staining protocol for the Kleihauer–Betke test to facilitate the reading of difficult cases These refinements aim to make “difficult” slides easier to read, but adoption across hospitals has been slow.
There is also a lower limit of detection to consider. Very small fetomaternal hemorrhages, generally those under a few milliliters, may simply not produce enough fetal cells on the slide to be noticed.
Flow Cytometry as a Modern Alternative
Flow cytometry identifies fetal cells by tagging fetal hemoglobin with fluorescent antibodies and running the sample through a laser-based counter, which eliminates the subjectivity of manual microscopy. It is faster, more reproducible, and less dependent on operator skill. One comparative study of clinical samples found moderate agreement between manual KB testing and flow cytometry, with a weighted kappa of 0.40, and moderate agreement between manual and automated KB testing, with a weighted kappa of 0.56.7PubMed. Quantification of fetomaternal hemorrhage: a comparative study of the manual and automated microscopic Kleihauer-Betke tests and flow cytometry in clinical samples Those kappa values translate to fair-to-moderate concordance, meaning the methods agree more often than chance but still diverge on a meaningful number of cases.
One drawback of flow cytometry in that study was that it only reliably detected fetomaternal hemorrhage above 0.1% of total cells. For very small hemorrhages, manual KB testing actually picked up cases that flow cytometry missed.8PubMed. Quantification of fetomaternal hemorrhage: a comparative study of the manual and automated microscopic Kleihauer-Betke tests and flow cytometry in clinical samples The Ethiopian study cited earlier found a good statistical correlation between KB and flow cytometry results overall, with a correlation coefficient of about 0.83 for categorized values and 0.90 for continuous values, and moderate agreement (kappa of 0.53).9BMC Pregnancy and Childbirth. Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia
So why hasn’t flow cytometry replaced the KB test entirely? Cost and availability. Flow cytometers are expensive instruments, and not every hospital laboratory has one running around the clock. The KB test requires only a microscope, some reagents, and a trained technician. In resource-limited settings, it is sometimes the only option. Canadian guidelines acknowledge both methods as acceptable for quantifying fetomaternal hemorrhage.10Journal of Obstetrics and Gynaecology Canada. Guideline No. 445: Prevention of Rh D Alloimmunization
False Positives and What Causes Them
The KB test assumes that any acid-resistant hemoglobin on the slide is fetal in origin. That assumption breaks down in certain situations. Adults normally carry a tiny amount of fetal hemoglobin in their blood, usually well under one percent. But some conditions push that level higher: sickle cell disease, thalassemia trait, hereditary persistence of fetal hemoglobin, and even some normal pregnancies where the mother’s own fetal hemoglobin production ticks upward. When maternal red blood cells carry elevated fetal hemoglobin, they resist the acid elution and stain darkly on the slide, mimicking the appearance of true fetal cells. Case reports have documented false-positive KB results caused by elevated maternal fetal hemoglobin F cells.11PubMed. False positive Kleihauer-Betke (acid elution) test caused by elevated maternal fetal haemoglobin F cells
This matters because a false-positive result could lead to unnecessary additional doses of anti-D immunoglobulin, extended fetal monitoring, or anxiety-inducing follow-up testing. If a clinician suspects that a positive KB result might be driven by the mother’s own hemoglobin rather than true fetal cells, flow cytometry can help clarify the picture, since antibody-based methods can distinguish between maternal and fetal sources of HbF more precisely than acid elution alone.
The Test After Maternal Trauma
Pregnant people who experience trauma, whether from a car accident, a fall, or an assault, are at risk of placental abruption and fetomaternal hemorrhage even when external injuries seem minor. The placenta does not need to fully detach for fetal blood to enter the maternal circulation; even a partial disruption of the placental surface can cause a bleed. One study of maternal trauma patients concluded that KB testing accurately predicts the risk of preterm labor after trauma, while clinical assessment alone does not. With a negative KB test, the researchers found that post-trauma electronic fetal monitoring could be safely limited in duration. With a positive test, the significant risk of preterm labor called for extended, detailed monitoring.12PubMed. Kleihauer-betke testing is important in all cases of maternal trauma
That study also made a point that sometimes gets lost in clinical discussions: KB testing offers advantages to all maternal trauma patients, regardless of Rh status.13PubMed. Kleihauer-betke testing is important in all cases of maternal trauma Most conversations about the KB test focus on Rh-negative mothers, because they are the ones who need anti-D immunoglobulin. But detecting fetomaternal hemorrhage matters for Rh-positive mothers too, because a large bleed threatens the fetus through blood loss, regardless of the mother’s blood type. In the trauma setting, the KB test functions less as a guide for immunoprophylaxis and more as a risk-stratification tool.
Routine Testing During Pregnancy Bleeding
Many hospitals reflexively order a KB test whenever a pregnant person presents with vaginal bleeding in the second or third trimester. The logic seems sound: bleeding might mean the placenta is disrupted, which might mean fetal blood is entering the maternal system. But evidence for the routine clinical value of this practice is thin. A recent study examining systematic KB testing in these cases concluded that it may have limited clinical utility, calling for further research to refine guidelines and optimize management.14PubMed. Pregnancy bleeding during second and third trimester: Is the Kleihauer-Betke test really useful?
The issue is not just accuracy. A retrospective study of over 660 women who were tested for suspected fetomaternal hemorrhage found that only about 3% had positive KB results, and fetal outcomes were not significantly different between the positive and negative groups. The test showed high specificity (97%) but very poor sensitivity (4%), with only moderate predictive values in either direction.15PubMed Central. Diagnostic accuracy of Kleihauer–Betke (Kb) testing to predict fetal outcomes associated with fetomaternal hemorrhage: a retrospective cohort study In plain terms, when the test was negative it rarely missed a large hemorrhage, but when it was positive it did not reliably predict a bad outcome for the baby. The authors concluded that KB testing offers no real diagnostic precision in the emergency triage of women with suspected fetomaternal hemorrhage. That is a strong statement, and it has fueled an ongoing debate about whether blanket KB testing in bleeding patients wastes resources and occasionally misleads clinicians.
Where the evidence does support testing is more targeted: after confirmed trauma, in cases of unexplained stillbirth, when neonatal anemia lacks an obvious explanation, and specifically for Rh-negative mothers who need accurate dosing of anti-D immunoglobulin. The gap between “test everyone who bleeds” and “test selectively when the result will change management” is where much of current clinical discussion sits.
When Fetomaternal Hemorrhage Is Massive
Most fetomaternal hemorrhages involve tiny volumes of blood, barely enough to register on a slide. But in rare cases, the hemorrhage is catastrophic. A fetus can lose enough blood across the placenta to become severely anemic while still in the uterus, a situation that can be fatal if not caught and treated. In one published case, a KB test on the mother’s blood showed 6% fetal cells, indicating a massive bleed. The fetus required five separate transfusions over 24 days, delivered through a combined intravascular and intraperitoneal route, to survive.16PubMed. Massive fetomaternal hemorrhage treated with serial combined intravascular and intraperitoneal fetal transfusions
Cases like these illustrate why the KB test persists despite its limitations. When a massive hemorrhage is suspected, even an imprecise quantification is better than none. A 6% fetal cell count on a KB smear translates to hundreds of milliliters of fetal blood in the maternal circulation, a volume incompatible with fetal survival without intervention. In these emergencies, the test provides a fast initial read that can mobilize a transfusion team while more precise confirmatory testing catches up.
Conditions That Overlap With or Complicate KB Interpretation
Beyond the false-positive issue from elevated maternal HbF, several other clinical scenarios complicate KB test interpretation. Twins and higher-order multiples present a challenge because the test cannot distinguish which fetus contributed the cells. If one twin is Rh-positive and the other Rh-negative, or if one twin is hemorrhaging while the other is not, the KB result gives a blended number with no way to tease apart individual contributions.
ABO incompatibility between mother and fetus can also confuse things. If the mother carries antibodies that rapidly destroy fetal red blood cells entering her circulation, those cells may be cleared before a blood sample is drawn, leading to a falsely low or negative KB result. The hemorrhage happened, but the evidence was cleaned up by the mother’s immune system before the lab could catch it.
Timing matters as well. The KB test is a snapshot of a moment. A fetomaternal hemorrhage can be ongoing, meaning a test done at the time of presentation might show a small bleed, while a repeat test hours later reveals a much larger one. For this reason, some protocols call for serial testing in high-risk situations, particularly after trauma, rather than relying on a single result.
Practical Points for Patients
If you are Rh-negative and pregnant, the KB test is most likely to come up after a sensitizing event: a fall, a car accident, a procedure like amniocentesis, or unexplained bleeding. Its purpose in your case is straightforward, to measure whether enough fetal blood has entered your system that you need more than the standard anti-D dose. The standard dose is given prophylactically at around 28 weeks and again after delivery in most protocols, but additional doses are needed if a large hemorrhage is confirmed.
If you are Rh-positive, you may still encounter the KB test if your care team suspects something has gone wrong with the placenta. In that context, the test is less about your blood type and more about assessing how much blood your baby may have lost. A positive result does not necessarily mean the baby is in danger, but it does mean your team will monitor more closely.
The test itself requires only a standard blood draw from you. There is no risk to the fetus. Results typically come back within a few hours, though turnaround varies by institution. If you are told the test “came back positive,” ask what the estimated volume is. A tiny positive result has very different implications than a result showing several percent fetal cells. And if your medical history includes sickle cell trait, thalassemia, or any condition associated with elevated fetal hemoglobin, mention it to your provider, because it can cause the test to overestimate the amount of fetal blood present.